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Abstract
Many conserved noncoding sequences function as transcriptional enhancers that regulate gene expression. Here, we report
that protein-coding DNA also frequently contains enhancers functioning at the transcriptional level. We tested the enhancer
activity of 31 protein-coding exons, which we chose based on strong sequence conservation between zebrafish and human,
and occurrence in developmental genes, using a Tol2 transposable GFP reporter assay in zebrafish. For each exon we
measured GFP expression in hundreds of embryos in 10 anatomies via a novel system that implements the voice-
recognition capabilities of a cellular phone. We find that 24/31 (77%) exons drive GFP expression compared to a minimal
promoter control, and 14/24 are anatomy-specific (expression in four anatomies or less). GFP expression driven by these
coding enhancers frequently overlaps the anatomies where the host gene is expressed (60%), suggesting self-regulation.
Highly conserved coding sequences and highly conserved noncoding sequences do not significantly differ in enhancer
activity (coding: 24/31 vs. noncoding: 105/147) or tissue-specificity (coding: 14/24 vs. noncoding: 50/105). Furthermore,
coding and noncoding enhancers display similar levels of the enhancer-related histone modification H3K4me1 (coding: 9/24
vs noncoding: 34/81). Meanwhile, coding enhancers are over three times as likely to contain an H3K4me1 mark as other
exons of the host gene. Our work suggests that developmental transcriptional enhancers do not discriminate between
coding and noncoding DNA and reveals widespread dual functions in protein-coding DNA.
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Introduction
The functions in a genome are often conceptually divided into
protein functions for coding DNA and regulatory functions for
noncoding DNA. This division is based on the intuition that
constraints associated with encoding a protein would prevent the
evolution of noncoding functions in a coding region. However, the
validity of this division has not been well-studied. One important
class of regulatory functional elements in noncoding DNA is
enhancers. These are DNA sequences classically found distal to
gene promoters and associated with tissue- or temporally-specific
transcriptional regulation of gene expression, especially for
developmental genes [1–8]. Here we investigate whether pro-
tein-coding DNA can contain enhancer functions similar to those
found in noncoding DNA.
Prior computational and evolutionary studies at the motif level
have shown that coding DNA can hold noncoding information.
This ability to contain other functional information arises from the
redundancy of synonymous codons. For example, Itzkovitz and
Alon compared the human genetic code to alternative permuted
codes, finding that the genetic code is nearly ideal for containing
short functional motifs within protein-coding DNA [9]. Using a
sequence conservation approach, hundreds of unusually conserved
nucleotide motifs have been found in coding sequences even after
correcting for protein-level constraint [10,11]. Additionally,
multiple genome-wide transcription factor and histone modifica-
tion studies have reported low-levels of protein binding within
coding sequence [12–14]. However, because a substantial fraction
of protein-DNA binding is believed to be neutral, it has often
assumed that such binding in coding regions is non-functional
[15]. In any case, assessments of functional motifs in coding
sequence do not strongly test the ability of protein coding sequence
to hold dual functions. This is because motifs are short in
comparison to mRNA lengths.
Protein-coding sequences can be more critically tested by
considering developmental enhancer activity. Developmental
enhancers are typically much longer than individual TF-binding
motifs and are often associated with strong sequence constraint.
Highly conserved noncoding sequences have shown frequent
enhancer activity in developmental expression assays [5,7,16]. For
example, three-fourths of noncoding sequences with .60%
human-teleost conservation have shown enhancer activity in
developmental assays [3]. Therefore discovery of developmental
enhancers in coding regions would indicate that long, highly
constrained regulatory functions can evolve in coding regions
despite the protein-coding constraint.
Relatively little is known about enhancers in coding sequence.
Coding exon-controlled enhancer activity has been reported in a
few cell line experiments, e.g. from the APOE, ADAMTS5 and
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provide more definitive evidence of developmental activity. Such
embryonic data is relatively sparse and has shown conflicting
results. Tumpel et al observed that the second exon of Hoxa2
contains a consistent but weak developmental enhancer within a
coding region, though reporter activity was found to be stronger
when the coding region was combined with an adjacent noncoding
sequence [20]. Similarly, Lampe et al identified a coding enhancer
in the first exon of Hoxa2 [21]. However, Woolfe et al tested three
coding sequences (from Sox21, Pax6 and SHH in zebrafish
developmental assay), but found little to no expression [5]. The
relative dearth of experimental data has made it unclear how
prevalent coding developmental enhancers are.
To address this question, we investigated the enhancer functions
of 31 coding sequences from a variety of developmental genes
orthologous between human and zebrafish. We chose Conserved
Coding Elements (hereafter CCEs) with strong conservation across
vertebrate species for this study, as we expected these might be
more likely to contain enhancers [22]. Using whole-embryo
experiments, we found that the coding sequence of many
developmental genes contains enhancers that drive tissue-specific
gene expression. Our results indicate that enhancers in coding
regions and in noncoding regions have similar levels of activity,
tissue-specificity and enhancer-associated histone modifications.
Thus the protein-coding constraint does not exclude noncoding
developmental regulatory information. Our work indicates that
complex additional functions may be commonly harbored in
protein-coding sequences of vertebrate genomes.
Results
Conserved Coding Elements Act as Enhancers
Conserved Coding Elements (CCEs) were identified using
minimal criteria of .60% DNA sequence conservation between
zebrafish and human, 100–1000 bp length, and occurrence within
a set of developmental genes orthologous between zebrafish and
human. These criteria were chosen to be similar to those used for
identifying Conserved Noncoding Elements (CNEs) in a previous
study of CNE enhancer activity [3] to allow for comparison of
CCEs and CNEs. CCEs meeting these criteria were refined to a
set of 31 for experimental testing with a range of conservation
levels and exon ranks (Data File S1 and Data File S4). 26 CCEs
corresponded to a complete zebrafish coding exon. The remaining
5 CCEs were Ultra Conserved Regions (UCRs) from the zebrafish
genome identified originally in Bejerano et al [1]. Each of these
UCRs exhibited partial overlap with a zebrafish coding exon. The
zebrafish-human conservation levels of the tested sequences
ranged from 67%–95% (avg. 79%). In comparison, zebrafish
coding exons have on average only 48% similarity with the human
sequence, and UTRs are only 9% similar. The test set has stronger
silent site conservation than other coding sequences as well (50%
4-fold conservation vs. 35% for random exons) [23,24].
We sub-cloned each CCE into a Tol2 vector, upstream of an
E1B minimal promoter driving EGFP (see Methods and Figure
S1). For each CCE, ,150–300 zebrafish embryos were injected at
the 1-cell stage with the vector and transposase mRNA. A control
vector containing the minimal promoter upstream of EGFP but
lacking an insert sequence was also assayed to assess the expression
of EGFP under the minimal promoter only.
Embryos were scored for EGFP transient expression at 22–30
hours in 10 anatomies. Transient expression of reporter genes in
zebrafish has been successfully used to identify noncoding
enhancers by several groups [3,5,8,25–31]. Such transient expres-
sion assessed over large numbers of embryos has been found to
yield enhancer assessments consistent with stable transgenics
[5,8,26]. To facilitate data input and analysis, we developed a
novel expression scoring technique that uses the voice recognition
capabilities of a cellular phone and custom PERL scripts to assess
significant expression of experimental constructs compared to the
control (see Methods and Figure 1). This technique allows for
simultaneous assessment of several dozen embryos in each
microscope viewing, resulting in increased numbers of scored
embryos and improved quantification of expression.
We identified CCE enhancers by comparing the fraction of
embryos with activity driven by the CCE to the fraction of
embryos with activity driven by the control, on an anatomy-
specific basis (see Methods, Figure S2). Thresholds were based on
a proportions test and non-parametric Wilcoxon test, and
anatomies with significant enhancer activity were required to
have p # 0.05 for both tests. For anatomies where we called
enhancer activity, an average of 64% of embryos showed activity.
For the 71 cases where our rule indicated significant CCE activity
in an anatomy, these anatomies displayed an average of 46higher
expression than the control plasmid, ranging from 1.66 at the
lowest to 146at the highest (Table 1 and Data File S2). No pair of
CCEs displayed the same set of active anatomies, indicating that
the observed enhancer activities were controlled by individual
CCE effects rather than systematic biases.
Weobservedthat24/31CCEs(77%)droveclearGFPexpression
abovethecontrol.Althoughtherewasasmallamountofmosaicism,
20/24 CCEs drove expression in at least one anatomy at a level
significantlygreaterthanthecontrol(FiguresS9,S10andS11).Each
of these CCEs drove expression in .35% of embryos, including 4
withexpressionin.80%ofembryos(TableS1).14/24(58%)CCEs
were anatomy-specific, defined as having activity in 4 or fewer
anatomies. Examples of anatomy-specific CCEs, in contrast to the
non-specific activity of CCE-ephb3a, are shown in Figure 2. The 7
CCEs which we assessed as non-functional exhibited expression
in,5% of embryos. The fraction of CCEs which we observed to
have enhancer activity was much higher than that of random
sequences with cryptic activity, as measured by Sanges et al. in a
transient co-injection assay (17%) [32].
To further confirm the validity of our assays, we made transgenic
lines for one CCE: CCE-lmo1, which we chose because of its strong
expressioninthetransientassay(seeMethods).Twotransgeniclines
displayed very strong GFP expression in the forebrain and
hindbrain, with excellent correspondence to the transient CCE-
lmo1 expression. A comparison of stable vs. transient behavior is
shown in Figure 3 (and Figure S3). The other two lines also showed
the same pattern, but with a weaker background likely due to
positionaleffects.Thisresultisconsistentwithpreviousfindingsthat
activity measured in Tol2-based transient enhancer assays can be
recapitulated in stable transgenics [3,26,33].
Coding and Noncoding Enhancers are Similar in Both
Activity and Tissue-Specificity
In a previous study we reported that 76/101 of CNEs, chosen
by criteria similar to those used for the CCEs, exhibited enhancer
activity as measured using methods similar to those applied to
CCEs [3]. We have since performed additional experiments to
raise these numbers to 105/147 (,71%). Our observed CNE
enhancer rate is comparable to that found in other studies that
have tested CNEs under conservation criteria relatively similarly to
ours [34], supporting our experimental approach.
As shown in Figure 4A, enhancer activity rates are not
significantly different between CCEs and CNEs (coding=24/31
vs. noncoding=105/147, p=.323). This indicates that there is no
significant bias of enhancer function for conserved coding versus
Transcriptional Enhancers in Protein-Coding Exons
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locational independence, active and inactive CCEs show no
difference in their average location within genes (Wilcoxon test on
exon-rank, p=.49). Furthermore, we compared tissue-specificity
(#4 anatomies) for the active CCEs and CNEs. As shown in
Figure 4B, 14/24 (,58%) coding enhancers are tissue specific, and
50/105 (,48%) noncoding enhancers are tissue specific, with no
significant difference between the two classes (p=.235).
We have previously shown that for CNEs with greater than
60% human-zebrafish conservation, increased conservation can-
not distinguish active and inactive CNEs [3]. Analogously,
increased conservation did not associate with greater propensity
for enhancer activity in our CCE set. 11 CCEs were the most
conserved exons in their containing genes, yet only 54% of these
yielded expression in at least one anatomy, lower than the overall
activity rate (see Data File S1). For CCEs with conservation of 70–
79%, 6/9 CCEs drove significant reporter expression; with
conservation of 80–89%, 12/18 CCEs drove expression. Thus
there was no increase in detecting enhancer activity with
conservation. Similarly, 4-fold site conservation was not stronger
for the sequences with activity (data not shown). The CCEs we
tested span a range of AT (34%–61%) and GC (38%–65%)
contents. The five most AT-rich CCEs all drive GFP expression,
as do the five most GC-rich CCEs. We found no significant
difference in activity for AT-rich CCEs. For example, for
sequences with AT content .50%, 12/14 CCEs show activity,
while for sequences with AT content,50%, 12/17 CCEs show
activity. These ratios are not statistically different (p=0.57). This
independence of activity from GC content is similar to what has
previously been observed for CNEs [3].
Activity Patterns of CCEs
To investigate the target genes of CCE enhancers, we compared
CCE activity to the anatomical expression of the gene in which the
CCE resides (hereafter termed ‘‘host’’ gene) using ZFIN anatomy
tags (see Methods and Figure S4). Our dataset contains 20 active
CCEs for which in situ mRNA expression of the zebrafish host
gene is available [35]. 12/20 CCEs display activity overlapping at
least one anatomy of host gene expression in the 22–30 hours post-
fertilization (hpf) time period (Data File S3). This is much more
overlap than when CCE activity is compared to the expression of
100 sets of 20 random genes (3.661.8, see Methods). Furthermore,
the CCE enhancer activities are more similar to expression of the
host gene than that of neighboring genes. Significantly fewer
CCEs have activity overlapping the expression of either the
upstream or downstream gene (upstream 4/20: p=0.02 and
downstream 2/20: p=0.003). This suggests that the target of a
coding enhancer is often the gene in which the enhancer resides.
Figure 5 displays examples of CCE activity consistent with
expression of the host gene. For example, CCE-lmo1 is a
conserved exon of a transcriptional regulatory gene, lmo1 [36].
CCE-lmo1 exhibits activity consistent with host gene expression in
the forebrain and hindbrain of the nervous system (see also, Figure
S5). Likewise, fasciculation and elongation protein zeta-1 (fez1) is
Figure 1. Overview of EGFP expression scoring process. (A) Zebrafish with eGFP expression are scored using a (B) limited anatomy
corresponding to (C) numerical values. (D) These are interpreted using the iPhone app Dragon Dictation. (E) A PERL script transforms text into
numerical strings representing embryo expression in each anatomy. These data are analyzed to determine anatomical regions with significant
expression for each CCE via a proportions test and a Wilcoxon rank-sum test (see Methods and Supplementary Data File S2).
doi:10.1371/journal.pone.0035202.g001
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displays expression in these areas. Similar behaviors are observed
for CCE-bysl and CCE-prim1.
In some of the non-overlapping cases, there is evidence for host
gene expression in the anatomies where the CCE is active. For
example, CCE-gria3b and CCE-islet1 both display strong heart
expression (see CCE-gria3b: Figure 2A, CCE-islet1: Figure S6).
While ZFIN lacks mRNA in situ heart annotations for either,
glutamate receptor gria3 has been reported active in mammalian
heart tissue [38], and islet1 has been reported in both mammalian
[39] and zebrafish heart [40]. Further investigation of such CCEs
may be useful, both for clarifying the regulatory target and for
their practical use in driving expression in the zebrafish heart [41].
A separate aspect of enhancer activity is that enhancers can be
active in multiple tissues. Such concurrent activity may be
functionally important, but mosaicism can often obscure recogni-
tion. An advantage of our method is that it yields activity
annotations for all anatomies on an embryo-by-embryo basis,
allowing us to quantitatively distinguish concurrent multi-anatomy
activity from mosaicism (see Methods, Figure S7). Ten CCEs
exhibit significant concurrent activity in at least one pair of
anatomies (p-value,.05), as shown in Table S2. For example
CCE-fez1 has significant concurrent activity in forebrain and
midbrain (p=1.3E-7), forebrain and eye (p=9.2E-5), and
midbrain and eye (p=9.2E-5) (Figure 6).
Table 1. Examples of Expression Data.
PLASMID NAME Control CCE-rab11fip4a X CCE-abca1a X CCE-odz3 X CCE-rfx2 X
Total Embryos Scored By Voice-
Recognition
161 53 43 39 48
Raw Expression proportion
Forebrain: 0.3354 0.4340 0.3488 0.8205 2.4 0.3750
Midbrain/Hindbrain: 0.2546 0.1509 0.3953 0.0256 0.1250
Eye: 0.1800 0.2264 0.4419 2.5 0.0769 0.1667
Ear/AboveHeart: 0.0680 0.0189 0.0698 0.2821 4.1 0.0208
Heart: 0.3160 0.2264 0.0000 0.1538 0.1042
Notochord: 0.1610 0.6038 3.8 0.3953 2.5 0.0769 0.1042
Yolk/YolkExtension: 0.1550 0.2075 0.3953 2.6 0.1282 0.2708
MidTrunk/AboveYolk: 0.0800 0.0943 0.0930 0.1538 0.0000
Muscle: 0.1800 0.1509 0.3488 0.5128 2.8 0.6875 3.8
TailRegion: 0.1240 0.1887 0.1163 0.2051 0.1667
p-values prop.test
Forebrain: 0.1289 0.5000 5.48E–08 0.3693
Midbrain/Hindbrain: 0.9147 0.0519 0.9983 0.9546
Eye: 0.2941 0.0003 0.9089 0.5000
Ear/AboveHeart: 0.8445 0.5000 0.0002 0.8127
Heart: 0.8595 1.0000 0.9660 0.9969
Notochord: 5.14E-10 0.0009 0.8627 0.7732
Yolk/YolkExtension: 0.2512 0.0006 0.5694 0.0539
MidTrunk/AboveYolk: 0.4904 0.5000 0.1373 0.9547
Muscle: 0.6094 0.0146 1.84E-05 2.44E-11
TailRegion: 0.1725 0.5000 0.1470 0.3028
p-values average 3 runs of wilcox.test
Forebrain: 0.1964 0.5680 0.0053 0.5038
Midbrain/Hindbrain: 0.9497 0.1371 0.9961 0.9711
Eye: 0.2282 0.0460 0.9572 0.7784
Ear/AboveHeart: 0.9744 0.7036 0.0287 0.9525
Heart: 0.9047 0.9981 0.9758 0.9950
Notochord: 0.0058 0.0057 0.9847 0.8387
Yolk/YolkExtension: 0.2801 0.0276 0.7832 0.1060
MidTrunk/AboveYolk: 0.5277 0.5800 0.2014 0.9966
Muscle: 0.7513 0.0524 0.0205 0.0051
TailRegion: 0.4191 0.5419 0.1681 0.2205
Raw Expression Proportion (top) displays the fraction of surviving embryos with expression in each anatomy. X column shows the ratio of expression fraction for
statistically significant anatomies. We consider anatomies as significant if they have p#0.05 for both the Wilcoxon and Proportions test (middle and bottom). The full
dataset can be found in Supplemental Data File S2.
doi:10.1371/journal.pone.0035202.t001
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Modifications
Histone3 Lysine4 monomethylation (H3K4me1) has previously
been associated with ,30–40% of enhancers in mammalian non-
coding regions [42–47]. Aday et al. previously tested 6 sequences
with H3K4me1 marks in zebrafish and showed that 4 exhibited
enhancer activity [48]. We analyzed the prevalence of this mark in
zebrafish at the same developmental timepoint as our enhancer
experiments, using an H3K4me1 ChIP-seq dataset specific for
zebrafish whole-embryo at 24 hours [48]. In our dataset, 9/24
(37.5%69.8% s.e.m.) of our CCEs with enhancer activity have an
H3K4me1 mark at that timepoint. In contrast, a much smaller
fraction of other exons in those genes show this mark (37/358,
10.3%61.6%). Similarly, H3K4me1 prevalence in CCE enhanc-
ers is much higher than the fraction of exons genome-wide which
show the H3K4me1 mark (8874/110461, 8.0%60.08%). In our
prior dataset of validated CNE enhancers from zebrafish, 34/81
(42%65.4%) have an H3K4me1 mark. This prevalence is not
significantly different from CCE enhancers (p=.56). The
H3K4me1 mark is more common in exons of developmental
genes (942/6741, 13.9%60.42%) than in exons genome-wide. On
a gene-wise level, 517/813 (63.6%61.7%) of developmental genes
have at least 1 exon with H3K4me1 binding, in comparison to
6362/13588 (46.8%60.43%) of genes overall. This is also higher
than the prevalence of H3K4me1 in size-controlled intronic
regions. Only 34.7%60.42% of such intronic regions contain an
H3K4me1 site. These findings indicate that H3K4me1 is active in
the coding sequences of developmental genes, and that H3K4me1
has a similar functional importance for enhancers in noncoding
and coding regions.
H3K4me1isnotaperfectpredictorofenhanceractivity,sinceonly
a subset of active CCEs show the mark. We note that in the more
comprehensively characterized human ENCODE datasets, recent
algorithms to predict enhancer activity from histone modifications
(includingH3K4me1)alsohavefalsenegativeratesof20–40%[43].
We also considered whether these active CCEs might function as
promoters rather than enhancers in their native context, as
H3K4me1 can also occur at promoters. If this were the case, we
would expect to find transcripts often beginning adjacent to CCE
sequences. Using the UCSC EST database, we did not find an
increase in adjacent transcripts. CCEs that drove significant
Figure 2. Specific and Non-Specific CCE Activity. (A) Examples of Specific CCE Activity. CCEs from the genes gria3b, rab11fip4a, prim1, and
abca1a each drove robust expression in a finely localized anatomical region. Overall, 14 CCEs produced this type of specific expression (defined as
expression in 4 or fewer anatomical regions). (B) This behavior contrasts with CCEs that drove robust but non-specific expression, such as CCE-
ephb3a. 6 of the active CCEs drove nonspecific expression.
doi:10.1371/journal.pone.0035202.g002
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have ESTs that begin adjacently (15/20=71% vs. 5/7=75%,
respectively).
Coding Exons are Commonly Bound by Enhancer-Related
and Histone Modifying Transcription Factors
p300 is a bromo-domain histone acetyl-transferase protein that
has been associated with enhancers found in noncoding regions.
To further determine whether enhancers are likely to be common
in coding regions, we reanalyzed the mouse p300 ChIP-seq data of
Visel et al. using CCDS coding exons, a stringently annotated set
of conserved exons between mouse and human [14,49]. 172/5118
(3.3%60.24%) of p300 binding sites overlap a CCDS coding
exon, which is higher than the fraction of the mouse genome
covered by CCDS exons (1.0%).
Figure 3. Comparison of CCE-lmo1 Stable and Transient Transgenic Expression. (A) Stable transgenic F1 embryos from two independently
generated lines displaying strong forebrain and hindbrain expression. Supplementary Figure S3 shows this behavior in a larger group of stable
transgenic embryos. (B) Similarly, three transient transgenic embryos injected with CCE-lmo1 display analogous forebrain and hindbrain expression.
doi:10.1371/journal.pone.0035202.g003
Figure 4. CCE and CNE Activity and Tissue Specificity. (A) Comparison of the fraction of enhancers active in conserved coding elements (CCEs)
and conserved non-coding elements (CNEs). CCEs and CNEs exhibit similar enhancer activity levels, with no significant difference in activity. (B)
Comparison of the fraction of enhancers exhibiting tissue specificity in CCEs and CNEs. While CNEs are marginally less tissue-specific, the difference is
not statistically significant.
doi:10.1371/journal.pone.0035202.g004
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transcription factor dataset from ENCODE [50] and deter-
mined overlap with human exons. 24095/326254
(7.3%60.04%) coding exons are bound by at least one
transcription factor. The top 5 exon-bound transcription factors
are HEY1 [51], TAF1 [52], BAF155 [53], POU2F2 [54] and c-
MYC [55], all of which have been shown to be associated with
enhancer activity. These factors are involved in both sequence-
specific binding (Hey1 and c-MYC bind the E-box [56,57]) and
histone modifications (TAF1, BAF155, POU2F2, c-MYC [57–
60]). This provides further support for transcription regulation
and enhancer activity in coding sequence.
CCEs May Contain Multiple Overlapping Functions
An alternate hypothesis for the function of highly conserved
coding sequences has been proposed to be ‘‘poison cassettes’’ [61].
According to this hypothesis, certain exons may be spliced-in as
alternative exons, and these poison-cassette exons then invoke
mRNA degradation through the nonsense mediated decay (NMD)
pathway via a premature stop codon. Lareau et al. previously
showed that poison cassette exons are also highly conserved,
suggesting that the high conservation in such exons may be related
to poison cassette activity. We were curious whether a poison
cassette exon would also display enhancer activity, as this would
suggest that the strong conservation of poison cassette exons is
coincidental to their NMD activity. We tested the enhancer
Figure 5. Representative images of CCE expression and host gene expression (mRNA in situ hybridization data from ZFIN) for 4
CCEs, showing overlap between CCE activity and host gene expression.
doi:10.1371/journal.pone.0035202.g005
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cassette exon in the splicing-regulator SRFS3 (Srp20) studied in
Lareau et al. This CCE has an internal stop codon and overlaps 23
known ESTs. Although the human ortholog of this exon exhibits
NMD-related poison cassette behavior, in zebrafish CCE-sfrs3b is
a robust enhancer and displays concurrent activity in the brain
and eye (Figure 7). In addition, CCE-sfrs3b has strong human-
zebrafish sequence conservation both before and after the stop
codon (each 83% id). This conservation pattern is consistent with
homogeneous selection on a larger enhancer element, in addition
to any constraints related to poison cassette activity or the amino
acid sequence.
Discussion
We have shown that conserved coding sequences often act as
enhancers, with activity, tissue-specificity and protein-binding
characteristics similar to highly conserved noncoding sequences
selected by analogous criteria. While we tested only 31 sequences,
Figure 6. CCE-fez1 drives expression in multiple anatomies, with significant concurrent activity in forebrain, mid/hindbrain and
eye. 4 representative embryos are shown.
doi:10.1371/journal.pone.0035202.g006
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conservation and overlap with genes active during forebrain
development. At our observed success rate (77%), this would imply
,129 coding enhancers in the zebrafish genome. In all likelihood
this is an underestimate, as there may be many coding enhancers
that do not meet our selection criteria. In any case, our work
demonstrates that even sophisticated regulatory functions such as
enhancers may occur commonly in protein coding sequence.
These experiments clearly verify the coding enhancer hypoth-
esis [62,63]. Previously, Dong et al. computationally investigated
whether exonic remnants of duplicated zebrafish coding sequences
might contain enhancers, finding that synteny, conservation, and
epigenetic data (from mammals) supported some exons having
enhancer activity. However, they experimentally tested only one
exonic remnant, a noncoding sequence originating from a
duplicated zebrafish Elp4 exon (,200 bp). They observed that
the exonic remnant influenced enhancer activity when contained
in a larger piece of noncoding sequence (,2000 bp), but the
exonic remnant alone was unable to drive consistent expression. A
similar issue confounds the interpretation of a study by Lampe et
al [21]. They showed that a 1.25 kb sequence containing the first
exon, intron and partial second exon of Hoxa2 had some
developmental enhancer activity. However, the first exon was
not shown to have developmental activity alone. Our experiments
provide a more direct demonstration that coding regions contain
enhancer functions, as almost all CCEs correspond exactly to a
single coding exon. In support of our findings, during the
processing of this manuscript another group communicated to us
evidence for transcriptional enhancers in coding exons that
regulate nearby genes [64].
Protein vs. Enhancer Function
The observation of prevalent coding enhancers is counterintu-
itive given that protein-coding constraints would be expected to
conflict with other functions in the same location. However the
degree of conflict depends on the amount of evolutionary
constraint associated with both the protein and other function.
Consider first the constraint associated with protein function.
Previous studies have shown that 70% of amino acids in a protein
can be altered while maintaining structure and function [65,66].
This indicates that if an enhancer were to arise in a coding region,
there would be substantial flexibility in the amino acid sequence to
accommodate the enhancer function, in addition to the flexibility
of changing synonymous sites. Consistent with this idea, we have
previously shown that for 6-mer motifs, nucleotide-level pressures
have commonly superseded protein-level constraints [10]. This
malleability of protein sequences suggests that coding enhancers
need not have much higher conservation than other coding
sequences.
The level of constraint associated with enhancer activity
remains controversial, as enhancers vary widely in their sequence
conservation. Conservation-blind enhancer identification ap-
proaches in noncoding regions have suggested that enhancers
are typically under strong sequence constraint. McGaughey et al.
tiled intergenic regions around the phox2b locus in zebrafish and
found that ,40% of sequences with enhancer activity had $75%
zebrafish-human conservation in a block $100 bp [34]. Kim et al
found that noncoding enhancers identified by p300 and methyl-
ation marks had phastCONS conservation scores (peak ,0.4)
higher than the background (,0.1) [46]. Visel et al. found that
,90% of p300 identified enhancers are under evolutionary
constraint [14]. However, there are also substantial deviations
from this typical behavior. Some sequences without overt
conservation act as enhancers [26,34,67]. Also, it has been found
that 40% of ultraconserved sequences display no enhancer activity,
though this conclusion is limited by the small number of
experimental conditions that have been probed [16]. These
variations make it difficult to determine how many bases are
necessary for each enhancer. Still, the lengths of highly conserved
coding and noncoding sequence blocks suggest that enhancers
span many dozens of bases [68].
Predicting Coding Enhancers
How should enhancers in coding regions be predicted? Given
that enhancer-protein conflict appears to be weak, this question is
essentially the same as for predicting enhancers in noncoding
Figure 7. CCE-sfrs3b, an alternatively spliced exon, is shown here to drive enhancer expression in the eye and brain, despite poison
cassette activity of the exon.
doi:10.1371/journal.pone.0035202.g007
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relatively high conservation (e.g. our criteria of .60% fish-human
ID over 100 bp) are important features, the application of which
should yield true positive rates of ,3/4. These criteria tend to
overlap – for the genome-wide set of exons with 1:1 orthology,
there are 8,693 exons (avg. conservation 77%) and many are from
developmental genes. There are 6274 exons from developmentally
expressed zebrafish genes, and 61% are at least 60% similar to
human. Even nonconserved sequences in developmental loci may
have substantial rates of enhancers. For example, McGaughey et
al found enhancer activity in 4/13 blocks of noncoding sequence
near the zebrafish phox2b developmental gene lacking conserva-
tion to fugu, tetraodon, human or mouse [34].
Extensions of sequence-based prediction approaches, e.g.
through superior neutral background models [69], may yield
improvements in true positive rates. However, we do see that
conservation and likelihood of enhancer activity have little
correlation at the high end of the conservation spectrum, and
predictive approaches based on presence of transcription factor
binding site sequence motifs, while beneficial, still have substantial
error rates [2,31,70]. Given these complexities, it will be difficult to
elucidate predictive features by testing ‘‘random’’ control sequenc-
es in embryos since the possible set of predictive features can not
be adequately surveyed in any small control set. Recent
approaches based on large-scale ChIP data for condition-specific
epigenetic features [14,71] are likely to be important if very high
true positive rates are desired. Interestingly, the lack of association
between extreme conservation and enhancer activity suggests that
the most conserved sequences may be conserved because they
have additional selective pressures, such as poison cassette activity,
layered on top of the enhancer activity. Other pressures might
include the exon-sharing that has been observed for Hox loci,
binding sites for microRNAs, or effects related to mRNA structure
[10,72,73]. These issues remain open, and it is likely that a much
larger number of exonic sequences will have to be experimentally
profiled and analyzed to resolve the interplay of such pressures.
Our work suggests that enhancers in coding regions target their
own gene. This finding is consistent with the genomic regulatory
block concept of Kikuta et al. that enhancers and their targets
should remain syntenic through evolution [74]; CCEs are a more
extreme form of this idea since the enhancer and target coincide.
In addition to being advantageous for modularity, this behavior
might be related to the mechanism of enhancer activity. For
example, Kim et al. reported that transcription commonly occurs
at enhancers [46] and Orom et al. found noncoding RNAs whose
DNA sequences have enhancer activity mediated by the
transcribed ncRNA [75]. Localization in transcribed regions
would provide CCEs an inherent feedback system for regulation of
the host gene.
Finally, this work sheds light on the many protein-binding,
histone modification, and RNA-binding events in coding DNA
which have typically been regarded as ‘experimental noise.’ Given
that coding sequence can contain enhancer functions, it is likely
that many of these events are functional as well. A number of
recent disease studies have shown the functional importance of
synonymous SNPs [76–78], and it is likely that similar functional
events in coding sequences have been substantially under
characterized.
Materials and Methods
Additional CCE images and the program to calculate significant
anatomies are available at the public website and database: http://
bioinformatics.bc.edu/chuanglab/CodingEnhancer.
Conserved Exonic Sequences and Ultra Conserved
Regions
To determine a set of CCEs, we identified exons with mutual
best BLAST hits among Ensembl RefSeq exons from zebrafish
(dr6) and human (GrCH37) with E-value,1e
210 [79]. The
average conservation of this set was 76.5% (8693 seqs,
s=11.6%). Exons from the set of 8693 sequences were filtered
for .60% conservation between zebrafish-human, .100 bp, and
lacking XhoI or BglII cut sites. Because the expression assay is
performed during development, a set of 250 human-zebrafish
orthologous forebrain/developmental genes from Ensembl was
used to filter potential experimental exons. 26 coding exons with
unique primers were chosen from the 168 sequences that met
these criteria based on considerations of exon rank and
conservation level. MultiZ vertebrate 6-way CDS Fasta alignments
from the UCSC Genome Browser were used for sequence analysis
[80]. Cross-species sequence identity was calculated from positions
wherein neither species exhibited a gap.
Additionally, 5 ultraconserved regions (UCRs) were chosen
from Bejerano et al. [1]. 4 of these overlap known Refseq coding
exons while the last one (CCE49 from SFRS3) overlaps an exon
known from human and zebrafish EST data and Ensembl
alternative transcript data. These UCRs also have .60%
conservation and are from the forebrain/developmental gene list.
UCR sequences were specified by liftover of the original hg16
coordinates to the hg19 and dr6 genomes. Alignments were based
on available pairwise hg19-dr5 alignments in Galaxy [81], and
correspondences with the dr6 sequences were verified manually.
Plasmid Creation and Sequencing
Primers were designed using the Primer3 executable [82]. The
primer search space was from the 25 bp within the CCE to 50 bp
outside with a preference for sites exactly matching the end of the
CCE. Genomic DNA was amplified from SH (Scientific Hatch-
eries) wildtype zebrafish using primer sequences with XhoI and
BglII end cut sites.
The plasmid (pT2KXIGQ) is a modification of the Tol2
plasmid pT2KXIG [83]: the longer Tol2 arm was shortened by
digestion with BglII and NruI, T4 fill-in and self ligation, and
fragment XhoI-SalI (EF1a) was replaced with the E1B minimal
promoter. Tol2 plasmids have been used by many groups for
enhancer studies in zebrafish due to their decreased mosaicism
and robust integration [7,26,48,84–86]. Our construct was
previously used in studies to characterize the presence/absence
of enhancer activity for .100 CNEs, and to characterize fezf2
binding sites [3,31,87]. Inserts were ligated in upstream of an E1B
minimal basal promoter 59 to EGFP. The insert and reporter gene
in the PT2KXIGQ construct are surrounded by ,300 bp Tol2
sequences on each side, which improves the function of expression
and integration of this vector compared to the full-length Tol2
plasmid [86]. The control plasmid was created by excision of the
plasmid insert, isolation of plasmid backbone, removal of
overhanging ends and T4 blunt-end ligation. All plasmid inserts
were sequenced for quality verification, and 25/31 sequences were
exact matches to the reference genome (Tu ¨bingen Wildtype). 5
differed by 1 base (CCEs bysl, ddx18, prim1, hif1an, erm,
rab11fip4a) and 1 differed by 2 bases (sfrs3b).
Zebrafish Embryo Injection
Pooled zebrafish embryos from AB and SH strains were
collected within 10 minutes of fertilization. 150–300 embryos were
injected per CCE with typically ,130 surviving. The amount of
injected plasmid DNA was consistent across CCEs and was very
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concentration of plasmid DNA aliquot was measured prior to
injection on a Nanodrop spectrophotometer. CCEs were generally
injected using 25 ng/mL plasmid and 30 ng/mL transposase (2 nL
injection). However, if a CCE had no expression at 25 ng/uL, the
concentration of plasmid and transposase was increased up to a
maximum of 35 ng/mL and 30 ng/mL transposase. Likewise, if
many embryos displayed abnormal development at the initial
concentrations, the experiment was discarded and the concentra-
tions of CCE and transposase were lowered to achieve normal
development. For 29/31 CCEs, 2 separate sets of injections were
performed on different days with different pooled WT fish crosses.
The control plasmid was injected in 4 separate rounds of WT fish
crosses.
Zebrafish Transgenic Line
150 zebrafish embryos were injected with plasmid LMO1. At
24 hpf, 50 fish were chosen with strong and specific expression.
,20 adults survived to adulthood and 6 were chosen to cross with
wildtype zebrafish. 4 of the 6 crosses resulted in GFP expression,
with around 30–40% of F1 offspring displaying GFP expression
similar to transient LMO1 expression.
Zebrafish Expression Scoring Using Voice Recognition
Embryos were visually scored for EGFP expression between
22–0 hours post-fertilization (judged by direct visualization of the
3-D living embryos from multiple viewing angles: dorsal, ventral,
lateral, oblique, etc.) Representative white-light and fluorescence
images were acquired at 5–20X. All CCEs and the control
plasmid were tested in multiple independent runs. Subsets of
embryos were anesthetized and plated (in sets of 15–20) onto
inverted 96-well cell culture dish lids. Embryos were scored using
the iPhone voice recognition application DragonDictation and a
controlled-language anatomy for 10 anatomical sections as shown
in Figure 1. A caveat is that our labeling does not distinguish all
the formal anatomical regions found in ZFIN (e.g. not
distinguishing anterior and posterior notochord). This is a
compromise between the known zebrafish anatomies and the
amount of feasible detail when many dozens of embryos are
being observed. The mobile phone was placed by the micro-
scope, freeing both hands for embryo sorting and scope
operation.
Resulting text files were manually reviewed and processed by a
PERL script and R Statistical Package [89], as shown in detail in
Figure S2. We required the CCE to meet two significance criteria
(p,.05) in order to be annotated with a particular anatomy. The
first is a proportions test (prop.test) using all scored embryos. We
required the fraction of all scored CCEs expressing in an anatomy
to be significantly greater than that of the control plasmid. The
second criterion accounts for variability over multiple rounds of
injections as follows: the voice-data from all embryos in all
injection sets for an individual CCE were shuffled and randomly
partitioned into 5 groups. For each of the 5 groups, the fraction of
embryos expressing was calculated. The values for these groups, as
well as the values from shuffling and random partitioning of voice
data for all injected sets of control embryos, were used as input for
a rank sum test of means (Wilcox.test). We required the mean rank
sum for the CCE to be significantly greater than the mean rank
sum of the control (see Data File S2).
Of note, our criteria to classify a CCE as having significant
expression in an anatomy are stringent. To determine enhancer
activity, previous publications have used thresholds of ,4% [5],
,7% [29], and ,10–20% [26] of embryos displaying GFP
activity. The lowest activity rate that we called as a significant
specific enhancer had .28% of embryos displaying expression
(ear region), which showed 7% activity in the control. We also
note that the (% expressing embryos) statistic exhibits a relatively
bimodal distribution. Of the 31 CCEs tested, 10 of them have a
(% expressing) value between 0 and 10%, which is the most
common decile. The next most common decile is from 50–60%,
with 9 CCEs in this range. Because of this bimodal behavior,
classification of active CCEs is relatively insensitive to the
threshold level.
To determine pairs of anatomies with concurrent activity, we
assumed a null hypothesis of equal probability for the four cases:
00, 01, 10, and 11, where 0 and 1 indicate absence or presence of
activity and the two digits correspond to the two anatomical
regions. A co-regulation z-score was calculated as z=(N11–0.25*
Ntotal)/(Ntotal * 0.25 * 0.75)
1/2 and a p-value was then calculated
based on a Normal approximation (see Figure S7).
Comparison of Enhancer Activity and Gene Expression
We downloaded the complete set of known anatomical
annotations for every gene in the zebrafish genome from Zfin
(10,746 unique genes). These annotations are based on literature-
curated in situ hybridization and PCR data [35]. We then
determined if the annotated expression domains of a given gene in
the 22–30 hour period of development (stages Segmentation:26+
somites to Pharyngula:Prim15) overlapped any of the 10
anatomical regions in each CCE’s activity annotation using
custom PERL scripts (see Figure S4). This approach removes
subjectivity in manual comparison of images and also allows one to
use the full set of ZFIN gene expression data, some of which do not
have images available.
The set of possible ZFIN anatomies was created by text-
matching anatomical descriptions for CCE significant anatomies
to ZFIN anatomical IDs. We also allowed for matches to IDs one
sub-level down in the ZFIN anatomical hierarchy to account for
variations in the resolution of anatomical annotations. For
example, ‘‘forebrain’’=ZFA:0000109. The immediate sub-level
down from forebrain contains the following terms: ‘‘diencepha-
lon’’=ZFA:0001343, ‘‘eminentia thalami’’=ZFA:0007010, ‘‘fore-
brain ventricle’’=ZFA:0000101, ‘‘telencephalon’’=ZFA:0001259
and ‘‘telencephalon diencephalon boundary’’=ZFA:0000079.
These 6 IDs were also used to query the ZFIN gene expression
database for matches to forebrain enhancer activity. This
matching flexibility is important when the mRNA expression
covers a diffuse area. For instance, CCE-ddx18 displays overlap-
ping expression with ddx18 mRNA in situ hybridization at in the
forebrain and midbrain at ,30 hpf, but the expression of the eye
and tectum make it difficult to determine whether there is
agreement on a finer scale (Figure S8).
To compare CCE expression to random genes, the host/
upstream/downstream and genes for the CCEs were removed
from the Zfin wildtype expression file, as were miRNA genes.
List::Util ‘Shuffle’ Perl module was used to randomly pick 20 genes
and assign to CCEs as ‘‘host genes.’’ The number of anatomies
shared between the CCE and the random host gene was then
counted. This process was repeated 100 times. The mean,
standard deviation and proportions analysis was done using the
R Statistical Package.
Comparison of CNEs and CCEs
To treat CNEs and CCEs equally, coordinates from experi-
mentally tested CNEs in Li et al [3] were lifted to the Zv8 build
using UCSC Genome Browser Lift Over [80]. Prop.test from R
Statistical Package [89] was used to calculate significance.
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H3K4me1 binding sites were obtained from the recently
published data of Aday et al. [48] and used for analysis. Zebrafish
(Zv9) exons and introns were obtained from UCSC Genome
Browser CDS Fasta records. The set of genes for the H3K4me1
analysis was determined by obtaining the flat database file
‘‘Expression Data for Wildtype Fish’’ from ZFIN. Developmen-
tally expressed genes were obtained by filtering anatomical staging
data for genes expressing in 0–30 h of fertilization by excluding
stages beyond Prim15 in the ‘EndStage’ column. To ensure higher
quality of expression, we kept records with RNA in situ
hybridization probe quality .=3. Exons were obtained by
converting the Zfin gene ID to the RefSeq gene name, then
using CDS Fasta records from the UCSC Genome Table Browser.
BedTools was used for overlap of histone modification markers
and zebrafish exons. Uncertainties listed in the main text refer to
standard error of the mean of a binomial variable given the
observed mean value and number of samples. For the EST
analysis, zebrafish ESTs were downloaded from the UCSC
Genome Browser. Using BedTools IntersectBed, 1 kb on either
side of the CCE was used to count ESTs that intersected but did
not completely overlap the 1 kb frame.
Four Fold Site Conservation
Human (hg19) and zebrafish exons (Zv8) for tested CCEs and
all exons from 100–1000 bp were extracted using CDS Fasta data
from the UCSC Genome Browser. Sequences were searched for
aligned 4-fold synonymous codons, and a minimum of five such
codons were required for further analysis. Four-fold sites were
extracted and the p-distance was calculated by counting the
number of conserved sites divided by the total number of sites.
Random exons were extracted using PERL to randomly shuffle
the set of all exons. Random exons were required to have alignable
coding sequence between human and zebrafish. The R Statistical
package was used for the unpaired Wilcoxon rank sum analysis.
p300 Analysis
p300 peaks were obtained from Visel et al. 2009 [14]. Peaks
were intersected with unique mm9 CCDS exons obtained from
the UCSC Genome Browser (154,896 exons) using IntersectBed
from BedTools [49,90]. Exons with duplicate or overlapping
annotations and any exons,3b po r.16 kbp were removed.
Clustered Transcription Factor Binding Site Analysis
TFBS clusters on 8 human cell lines were obtained from the
UCSC Genome Browser Encode Project [50]. Human exons from
Hg18 were obtained from CDS Fasta records. The TFBS cluster
score was .=500 (maximum possible 1000), and we required
100% coverage of the exon by the TFBS cluster. BedTools was
used for overlap of Hg18 exons and clustered TFBS.
Supporting Information
Figure S1 Plasmid Design and Injection. Flanking Tol2
sequences integrate the control or experimental cassette into the
zebrafish genome after injection with plasmid and transposase
mRNA at the 1-cell stage.
(TIF)
Figure S2 Processing Voice-Operated Anatomical Expression
Analysis. A schematic representation of how the proportions and
Wilcoxon rank-sum test compare CCE-slc1a2 expression in the
forebrain and yolk to the background expression of the control
plasmid lacking an insert. Only anatomies with p,.05 by both tests
were considered significant. The full datasheet containing p-values
for both tests and proportions for experimental inserts and the
control is Supplemental Data File S2.
(TIF)
Figure S3 A group of stable transgenic embryos (F1) derived
from embryos injected with CCE-lmo1. Injected embryos were
selected for forebrain and hindbrain expression and then crossed
with wildtype zebrafish to yield the F1 generation.
(TIF)
Figure S4 Anatomy Comparison Using Zfin. For the host/
upstream/downstream genes, the Zfin gene expression database
was queried using anatomical terms corresponding to our CCE
anatomies. The number of unique shared anatomies was counted
for each CCE-gene comparison. CCEs with at least 1 shared
anatomy with the gene were assigned a score of ‘‘1’’ while CCEs
without were assigned ‘‘0.’’ The number of CCEs with a match
was counted. Since there were 20 CCEs to be tested, in the
randomized control the same procedure was used but with 100
random sets of 20 genes.
(TIF)
Figure S5 Comparison of CCE-lmo1 expression to Zfin stages.
CCE-lmo1 maintains strong similarity to the mRNA in situ
hybridization of LMO1 throughout a large window of develop-
ment (22–42 hpf).
(TIF)
Figure S6 CCE-islet expression in the heart.
(TIF)
Figure S7 Concurrent Anatomical Activity Schematic. Each
anatomy pair is compared to a null expectation of equal likelihood
of expression in each of four cases: 00, 01, 10, 11. The first position
represents the first anatomy, the second position represents the
second anatomy. A 0 represents no expression and 1 represents
expression.
(TIF)
Figure S8 CCE-ddx18 displays expression in the forebrain and
midbrain, consistent with annotations in the ZFIN database.
However, the diffuse expression patterns around the tectum and
eye (particularly at ,22–24 hpf) make it difficult to visually
determine whether there is agreement on a finer scale.
(TIF)
Figure S9 Images from the 20 significant CCEs and their
corresponding anatomies. Images are labeled with (CCE-Gene-
Name, ExonNumber), and the significant anatomy for each CCE
is labeled. To view more images for each CCE, please visit: http://
bioinformatics.bc.edu/chuanglab/CodingEnhancer
(TIFF)
Figure S10 Images from the 20 significant CCEs and their
corresponding anatomies. Images are labeled with (CCE-Gene-
Name, ExonNumber), and the significant anatomy for each CCE
is labeled. To view more images for each CCE, please visit: http://
bioinformatics.bc.edu/chuanglab/CodingEnhancer
(TIFF)
Figure S11 Images from the 20 significant CCEs and their
corresponding anatomies. Images are labeled with (CCE-Gene-
Name, ExonNumber), and the significant anatomy for each CCE
is labeled. Note that CCE-ddx5 has voice-expression data but
lacks an image of yolk expression. To view more images for each
CCE, please visit: http://bioinformatics.bc.edu/chuanglab/
CodingEnhancer
(TIFF)
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for Whole Embryo (non-anatomy based)
(TIF)
Table S2 CCE concurrent activity. 10 CCEs display concurrent
activity in at least two anatomies with p,.05 compared to a null
expectation of equal likelihood of expression in each of four cases:
00, 01, 10, 11. The first position represents the first anatomy, the
second position represents the second anatomy, 0 represents no
expression and 1 represents expression. CCEs with z-score.3 are
highlighted in red.
(TIF)
Data File S1 Data file of zebrafish-human exon conservation.
ExonConservation_AllExonsInGene tab: The average of all exons
in the gene is highlighted in yellow, the CCE tested in marked in
red text. Exon-Cons,Total,Rank tab: a table of the average
conservation, the CCE conservation, the exon rank of the CCE,
and a count of exons in the gene.
(XLS)
Data File S2 Data file of wilcox.test and prop.test scores. The
raw expression proportion (top) displays the fraction of surviving
embryos with expression in each listed anatomy. X (green) shows
the ratio of expression fraction for statistically significant
anatomies, which are highlighted in yellow. We consider
anatomies as significant if they have p#0.05 (shown in red) for
both the Wilcoxon and Proportions test (middle and bottom).
(XLS)
Data File S3 Data file of CCE activity patterns. CCE_Host-
GeneComparison tab: lists the CCE, the anatomies of experi-
mental GFP expression, the ZFIN ID of the CCE-containing gene,
the anatomies of gene expression in ZFIN database. Expression
information for the closest upstream and downstream gene is also
listed. RandomlyAssignedGenes tab: Counts of matching expres-
sion for 100 sets of 20 randomly assigned genes. CCE_GEN-
E_UPSTREAM_DOWNSTREAM tab: ZFINID and common
gene name for the CCE-containing gene, and the closest upstream
and downstream genes. ExtendedAnatomy tab: Relational anat-
omy tags from the ZFIN database assigned to the anatomy tags
used to visually score GFP in zebrafish embryos.
(XLS)
Data File S4 Expression, location and conservation of 31
Conserved Coding Elements. 20 CCEs display significant
expression: 14 CCEs display significant specific expression (#4
anatomies) and 6 display significant non-specific expression. In
addition 4 CCEs display weak expression, and 7 CCEs fail to
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